Rocket One (RKTO) Total Current Liabilities (2017 - 2026)
Rocket One's (RKTO) quarterly Total Current Liabilities came in at $1.4 million in Q2 2026, up 279.49% year-over-year from $364630.0 in Q2 2025, and down 3.41% quarter-over-quarter from $1.4 million in Q1 2026.
Analysis
Rocket One (RKTO) Total Current Liabilities (2017 - 2026) Analysis & Trends
Rocket One has disclosed Total Current Liabilities across 10 years of filings, most recently posting $1.4 million for Q2 2026.
- In Q2 2026, Total Current Liabilities rose 279.49% year-over-year to $1.4 million; the TTM figure through Jun 2026 stood at $1.4 million (up 279.49% YoY), while the FY2025 annual figure was $1.5 million, up 74.77% from the prior year.
- Total Current Liabilities came in at $1.4 million for Q2 2026 at Rocket One, down from $1.4 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $1.7 million in Q2 2023 to a low of $364630.0 in Q2 2025.
- Average Total Current Liabilities over 5 years is $1.0 million, with a median of $919812.0 recorded in 2022.
- Year-over-year, Total Current Liabilities tumbled 60.33% in 2024 and soared 279.49% in 2026.
- Over 5 years, Total Current Liabilities stood at $1.4 million in 2022, then slumped by 51.1% to $678657.0 in 2023, then climbed by 22.48% to $831197.0 in 2024, then surged by 74.77% to $1.5 million in 2025, then fell by 4.75% to $1.4 million in 2026.
- Per Business Quant data, the three most recent Total Current Liabilities figures were $1.4 million in Q2 2026, $1.4 million in Q1 2026, and $1.5 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | 25.50 Bn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | 11.02 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | 3.94 Bn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | 5.53 Bn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | 1.58 Bn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | 2.53 Bn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | 1.51 Bn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | 3.92 Bn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | 283.60 Mn |
| 10 | Rocket One | 13.86 Mn | 5.97 Mn | - | 1.38 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.38 Mn |
| Mar 31, 2026 | 1.43 Mn |
| Dec 31, 2025 | 1.45 Mn |
| Sep 30, 2025 | 1.01 Mn |
| Jun 30, 2025 | 364,630.00 |
| Mar 31, 2025 | 815,299.00 |
| Dec 31, 2024 | 831,197.00 |
| Sep 30, 2024 | 810,324.00 |
| Jun 30, 2024 | 680,816.00 |
| Mar 31, 2024 | 639,834.00 |
| Dec 31, 2023 | 678,657.00 |
| Sep 30, 2023 | 1.58 Mn |
| Jun 30, 2023 | 1.72 Mn |
| Mar 31, 2023 | 1.35 Mn |
| Dec 31, 2022 | 1.39 Mn |
| Sep 30, 2022 | 1.01 Mn |
| Jun 30, 2022 | 753,672.00 |
| Mar 31, 2022 | 825,763.00 |
| Dec 31, 2021 | 867,787.00 |
| Sep 30, 2021 | 1.61 Mn |